News

Immunetune will be attending Biotech Wednesday on November 20 in Utrecht, the Netherlands. Reach out to us through the networking app or contact us directly in case you'd like to learn more about Immunetune's approach to fight cancer. More information on this meeting...

CSO Jeroen van Bergen will be presenting key highlights of Immunetune's preclinical proof-of-concept results at the Neoantigen summit in Boston, USA on November 20-22, 2019.

Gerben C.M. Zondag, CEO of Immunetune, will attend the BIO-Europe meeting in Hamburg, November 11-13, 2019.   Feel free to request a meeting if you'd like to hear more about possible partnering of investment opportunities.

CSO Jeroen van Bergen will be presenting key highlights of Immunetune's preclinical proof-of-concept results at the Neoantigen summit in Boston, USA on November 20-22, 2019.

Gerben C.M. Zondag, CEO of Immunetune, will attend the BIO-Europe meeting in Hamburg, November 11-13, 2019.   Feel free to request a meeting if you'd like to hear more about possible partnering of investment opportunities.

Funding for a 2-year research collaboration entitled "Improved personalized vaccines against cancer: quality of T cell immunity matters" has been awarded by Health Holland. In this project Immunetune will collaborate with Leiden University Medical Center to...

Wanda Han is one out of two recipients of a personal grant for talented biomedical professionals in start-ups to attend an International Course on Clinical Development organised by Paul Janssen Futurelab in Leiden, the Netherlands. For more information click here